机构:[1]Department of Urology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.[2]Beijing Diabetes Institute, Beijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.首都医科大学附属北京同仁医院临床科室内分泌科研究所糖尿病研究所[3]Department of Endocrinology, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.北京朝阳医院[4]Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
National Natural Science Foundation of
China (nos. 81730073 and 81872074 to L.W.); National Key R&D Program
of China (nos. 2021YFA0804800 and 2018YFA0800600 to J.L.); National
Natural Science Foundation of China (no. 8200032 to G.W.); Beijing Chao-
Yang Hospital Golden Seeds Fundation (no. CYJZ202122 to H.S.).
第一作者机构:[1]Department of Urology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Dong Kai,Wei Gang,Sun Honglin,et al.Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics[J].CURRENT OPINION IN PHARMACOLOGY.2023,68:102322.doi:10.1016/j.coph.2022.102322.
APA:
Dong Kai,Wei Gang,Sun Honglin,Gu Di,Liu Junli&Wang Linhui.(2023).Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics.CURRENT OPINION IN PHARMACOLOGY,68,
MLA:
Dong Kai,et al."Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics".CURRENT OPINION IN PHARMACOLOGY 68.(2023):102322